C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 403/06 (2006.01) A61K 31/41 (2006.01) A61K 31/435 (2006.01) A61P 29/00 (2006.01) C07D 413/06 (2006.01) C07D 417/06 (2006.01)
Patent
CA 2620173
In its many embodiments, the present invention relates to a novel class of phenylmorpholine and phenylthiomorpholine compounds useful as a2C adrenergic receptor agonists, pharmaceutical compositions containing the compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the a2C adrenergic receptor agonists using such compounds or pharmaceutical compositions.
L'invention concerne, dans ses diverses formes d'exécution, une nouvelle classe de composés de phénylmorpholine et de phénylthiomorpholine utilisés comme agonistes du récepteur a2C adrénergique, des compositions pharmaceutiques contenant ces composés, et des procédés de traitement, de prévention, d'inhibition ou d'amélioration d'une ou de plusieurs maladies associées à des agonistes du récepteur a2C adrénergique au moyen desdits composés ou desdites compositions pharmaceutiques.
Aslanian Robert G.
Biju Purakkattle J.
Boyce Christopher W.
de Lera Ruiz Manuel
Guise-Zawacki Lisa
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
Pharmacopeia Inc.
Schering Corporation
LandOfFree
Alpha2c adrenoreceptor agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Alpha2c adrenoreceptor agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alpha2c adrenoreceptor agonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1387946